777 related articles for article (PubMed ID: 15180713)
21. The diagnosis of gastroesophageal reflux disease.
Dughera L; Navino M; Cassolino P; Pellicano R
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):143-52. PubMed ID: 17557042
[TBL] [Abstract][Full Text] [Related]
22. Bile acids and Barrett's oesophagus: a sine qua non or coincidence?
Sital RR; Kusters JG; De Rooij FW; Kuipers EJ; Siersema PD
Scand J Gastroenterol Suppl; 2006; (243):11-7. PubMed ID: 16782617
[TBL] [Abstract][Full Text] [Related]
23. Functional foregut abnormalities in Barrett's esophagus.
Stein HJ; Hoeft S; DeMeester TR
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):107-11. PubMed ID: 8419690
[TBL] [Abstract][Full Text] [Related]
24. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
25. Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?
Tefera L; Fein M; Ritter MP; Bremner CG; Crookes PF; Peters JH; Hagen JA; DeMeester TR
Am Surg; 1997 Oct; 63(10):933-6. PubMed ID: 9322676
[TBL] [Abstract][Full Text] [Related]
26. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
27. Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?
Coenraad M; Masclee AA; Straathof JW; Ganesh S; Griffioen G; Lamers CB
Am J Gastroenterol; 1998 Jul; 93(7):1068-72. PubMed ID: 9672332
[TBL] [Abstract][Full Text] [Related]
28. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
29. Acid and duodenogastroesophageal reflux after esophagectomy with gastric tube reconstruction.
Yuasa N; Sasaki E; Ikeyama T; Miyake H; Nimura Y
Am J Gastroenterol; 2005 May; 100(5):1021-7. PubMed ID: 15842574
[TBL] [Abstract][Full Text] [Related]
30. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
31. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
32. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
33. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
[TBL] [Abstract][Full Text] [Related]
34. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
Ouatu-Lascar R; Triadafilopoulos G
Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
[TBL] [Abstract][Full Text] [Related]
35. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
Katzka DA; Castell DO
Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous bilimetry and pHmetry in GERD and Barrett's patients.
Felix VN; Viebig RG
Hepatogastroenterology; 2005; 52(65):1452-5. PubMed ID: 16201094
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus.
Waśko-Czopnik D; Błoński W; Paradowski L
Adv Med Sci; 2007; 52():196-8. PubMed ID: 18217418
[TBL] [Abstract][Full Text] [Related]
38. Current medical management of gastroesophageal reflux disease.
Locke GR
Thorac Surg Clin; 2005 Aug; 15(3):369-75. PubMed ID: 16104127
[TBL] [Abstract][Full Text] [Related]
39. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
[TBL] [Abstract][Full Text] [Related]
40. Gastroesophageal reflux in patients with laryngeal disorders.
Vanhemmens S; Wellens W; Tack J
B-ENT; 2005; 1(3):117-23. PubMed ID: 16255496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
